Home › Non-Muscle Invasive Bladder Cancer › Pennsylvania › Lancaster
Non-Muscle Invasive Bladder Cancer clinical trials in Lancaster, PA
3 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in and around Lancaster (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
RecruitingPhase 2
- Keystone Urology Specialists, Lancaster
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
RecruitingPhase 3
- Keystone Urology Specialists, Lancaster
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RecruitingPhase 1
- Penn Medicine Lancaster General Hospital - Ann B. Barshinger Cancer Institute, Lancaster
Non-Muscle Invasive Bladder Cancer trials in other cities
- Columbus, OH10 studies
- Dallas, TX10 studies
- New York City, NY10 studies
- Myrtle Beach, SC9 studies
- Edison, NJ9 studies
- Baltimore, MD8 studies
- Nashville, TN8 studies
- Syracuse, NY8 studies
- Houston, TX7 studies
- Indianapolis, IN7 studies
- Birmingham, AL7 studies
- Philadelphia, PA7 studies
Other studies in Lancaster
- Non-Small Cell Lung Cancer7 studies
- Cardiovascular Disease5 studies
- Heart Failure5 studies
- Breast Cancer4 studies
- Prostate Cancer4 studies
- Metastatic Cancer4 studies
- Lung Cancer3 studies
- Amblyopia3 studies
- Heart Diseases3 studies
- Bladder Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.